To present recent literature regarding the assessment and clinical implications of background parenchymal enhancement on breast MRI.The qualitative assessment of BPE remains variable within the literature, as well as in clinical practice. Several different quantitative approaches have been investigated in ...
Preliminary work has demonstrated that background parenchymal enhancement (BPE) assessed by radiologists is predictive of future breast cancer in women undergoing high-risk screening MRI. Algorithmically assessed measures of BPE offer a more precise and reproducible means of measuring BPE than human ...
Background parenchymal enhancement (BPE)To evaluate the influence of the amount of fibroglandular breast tissue (FGT) and background-parenchymal enhancement (BPE) on lesion detection, quantitative analysis of normal breast tissue and of breast lesions on DWI. IRB approved this retrospective study on ...
To evaluate the relationship of the extent and quantitative intensity of background parenchymal enhancement (BPE) on contrast-enhanced spectral mammography (CESM) with age, breast density, menstruation status, and menstrual cycle timing. This retrospective study included women who underwent CESM from July...
A contrast-enhanced breast MRI shows that normal FGT 'enhances' (background parenchymal enhancement, BPE) after contrast agent is administered(Morris EA. Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am 2007; 45: 863-880, vii., Kuhl C. The current ...
Comparison of Background Parenchymal Enhancement on Contrast-Enhanced Spectral Mammography and Breast Magnetic Resonance ImagingSogani, JulieMorris, Elizabeth AKaplan, Jennifer BD'Alessio, Donna DGoldman, Debra AMoskowitz, ChayaJochelson, Maxine S
Mammographic density, MRI background parenchymal enhancement and breast cancer risk. Mammographic density (MD), representing connective and epithelial tissue (fibroglandular tissue, FGT) is a major risk factor for breast cancer. In an analy... Pike,C M.,Pearce,... - 《Annals of Oncology》 被...
To retrospectively investigate whether the lesion-to-background parenchymal signal enhancement ratio (SER) on breast MRI can distinguish pathological compl... SY Kim,N Cho,Shin, Sung UiLee, Han-ByoelHan, WonshikPark, In AeKwon, Bo RaKim, Soo YeonLee, Su HyunChang, Jung MinMoon, Woo Kyung...
breast cancerbreast MRIendocrine therapyneoadjuvant therapyradiomicsNeoadjuvant endocrine therapy (NET) is increasingly used for the treatment of estrogen receptor positive, HER2 negative breast cancer. We evaluated whether MRI phenotype and background parenchymal enhancement (BPE) can predict response to NET...
Breast tissue enhances on contrast MRI and is called background parenchymal enhancement (BPE). Having high BPE has been associated with an increased risk of breast cancer. We examined the relationship between BPE and the amount of fibroglandular tissue on MRI (MRI-FGT) and breast cancer risk ...